Skip to content
Screener

RenovoRx RNXT Q3 2025 earnings

Reported November 13, 2025 · After market close

Revenue$266.0KMiss by $139.4K
EPS-$0.08In line
Revenue estimate$405.4K
EPS estimate-$0.08

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$952.0K
EPS estimate-$0.05

FAQ

When did RenovoRx report Q3 2025 earnings?
RenovoRx (RNXT) reported Q3 2025 earnings on November 13, 2025 after market close.
What were RenovoRx's Q3 2025 revenue and EPS?
RenovoRx reported revenue of $266.0K and eps of $-0.08 for Q3 2025.
Did RenovoRx beat estimates in Q3 2025?
Revenue missed the consensus estimate of $405.4K by $139.4K. EPS beat the consensus estimate of $-0.08 by $0.00.
How did RenovoRx's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 20.0% from $-0.10.
Where can I find RenovoRx's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001493152-25-022325) and the 10-Q periodic report (0001493152-25-022304) directly on SEC EDGAR. The filing index links above go to sec.gov.